This Malaria Policy Center blog post describes the event “Spurring health and wealth through medical breakthroughs,” during which Washington Post columnist and ONE Fellow Michael Gerson; John Lusingu, principal research scientist at the Tanzania National Institute for Medical Research and co-principal investigator in the RTS,S malaria vaccine trial in Tanzania…
Sabin Vaccine Institute, Texas Children’s Hospital, Baylor College Of Medicine To Create Tropical Disease Research School
Peter Hotez, chair of the Department of Microbiology, Immunology, and Tropical Medicine at George Washington University and president of Sabin Vaccine Institute, “will join the staffs of Texas Children’s Hospital and Baylor College of Medicine this summer, [and] will serve as founding dean of a new, as yet unnamed, tropical disease research school at Baylor,” the Houston Chronicle reports (Christian, 6/8).
Widespread Vaccination Could Save Millions Of Child Lives, Billions Of Dollars, Health Affairs Studies Say
About 6.4 million “children’s lives and billions of dollars could be saved if vaccines were more widely available in 72 of the world’s poorest countries,” according to a series of studies published Thursday in the June 2011 issue of Health Affairs, Reuters reports.
Researchers and “advocates for all vaccine research today launched yet another effort to increase funding and coordination,” ScienceInsider reports.
In this report from the Center for Strategic and International Studies, released ahead of the GAVI Alliance pledging conference, authors Lisa Carty, J. Stephen Morrison, Margaret Reeves, and Amanda Glassman write, “Its many achievements notwithstanding, GAVI still needs a strategic approach in the coming years if it is to deepen…
GlaxoSmithKline and drug company Crucell, a division of Johnson & Johnson, will collaborate with the PATH Malaria Vaccine Initiative to test a second-generation malaria vaccine “within the next couple of months,” Reuters reports.
The GAVI Alliance has appealed to donors for $3.7 billion to be pledged during an upcoming conference despite announcements by several major pharmaceutical companies to lower the prices of their vaccines for childhood diseases, the Associated Press/Washington Post reports (6/6).
Several pharmaceutical companies have pledged to lower the prices of vaccines against childhood illnesses ahead of the GAVI Alliance conference in London next week, the Guardian reports (Quinn, 6/6).
In his Washington Post column, Michael Gerson writes about British Prime Minister David Cameron’s approach to budget cuts.
“Considering its wealth, the U.S. spends relatively little on humanitarian aid that can make an enormous difference in the lives of millions of people â€“ and in the perception of the U.S. around the world. Nothing this nation could do with $450 million would surpass the good accomplished with a vaccination pledge to GAVI,” according to a Detroit Free Press editorial, which calls for President Barack Obama to provide $450 million over three years for the GAVI Alliance (6/1).